JP2025501169A5 - - Google Patents
Info
- Publication number
- JP2025501169A5 JP2025501169A5 JP2024539090A JP2024539090A JP2025501169A5 JP 2025501169 A5 JP2025501169 A5 JP 2025501169A5 JP 2024539090 A JP2024539090 A JP 2024539090A JP 2024539090 A JP2024539090 A JP 2024539090A JP 2025501169 A5 JP2025501169 A5 JP 2025501169A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- formulation according
- parenteral formulation
- bond
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163293985P | 2021-12-27 | 2021-12-27 | |
| US63/293,985 | 2021-12-27 | ||
| US202263313472P | 2022-02-24 | 2022-02-24 | |
| US63/313,472 | 2022-02-24 | ||
| PCT/US2022/053935 WO2023129502A1 (en) | 2021-12-27 | 2022-12-23 | Respiratory stimulant parenteral formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501169A JP2025501169A (ja) | 2025-01-17 |
| JP2025501169A5 true JP2025501169A5 (https=) | 2026-01-05 |
Family
ID=86992921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539090A Pending JP2025501169A (ja) | 2021-12-27 | 2022-12-23 | 呼吸刺激薬非経口製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230210857A1 (https=) |
| EP (1) | EP4456900A4 (https=) |
| JP (1) | JP2025501169A (https=) |
| KR (1) | KR20240150426A (https=) |
| AU (1) | AU2022426492A1 (https=) |
| CA (1) | CA3242509A1 (https=) |
| MX (1) | MX2024008162A (https=) |
| TW (1) | TW202333732A (https=) |
| WO (1) | WO2023129502A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230414624A1 (en) * | 2022-06-24 | 2023-12-28 | Enalare Therapeutics Inc. | Methods of treating neurological ventilatory insufficiency |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199901968T2 (xx) * | 1996-12-24 | 1999-12-21 | Biogen, Inc. | Sabit s�v� interferon form�lleri. |
| US20120295911A1 (en) * | 2010-11-29 | 2012-11-22 | Galleon Pharmaceuticals, Inc. | Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases |
| AU2011336764B2 (en) * | 2010-11-29 | 2017-02-23 | Galleon Pharmaceuticals, Inc. | Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases |
| DK2701684T3 (en) * | 2011-04-28 | 2017-09-18 | Platform Brightworks Two Ltd | Improved parenteral formulations of lipophilic pharmaceuticals and methods for their preparation and use |
| SG11201503505QA (en) * | 2012-11-15 | 2015-06-29 | Galleon Pharmaceuticals Inc | Novel orally bioavailable breathing control modulating compounds, and methods of using same |
| GB201502412D0 (en) * | 2015-02-13 | 2015-04-01 | Canbex Therapeutics Ltd | Therapeutic use |
-
2022
- 2022-12-23 WO PCT/US2022/053935 patent/WO2023129502A1/en not_active Ceased
- 2022-12-23 US US18/088,137 patent/US20230210857A1/en active Pending
- 2022-12-23 EP EP22917259.8A patent/EP4456900A4/en active Pending
- 2022-12-23 CA CA3242509A patent/CA3242509A1/en active Pending
- 2022-12-23 JP JP2024539090A patent/JP2025501169A/ja active Pending
- 2022-12-23 KR KR1020247025381A patent/KR20240150426A/ko active Pending
- 2022-12-23 AU AU2022426492A patent/AU2022426492A1/en active Pending
- 2022-12-23 MX MX2024008162A patent/MX2024008162A/es unknown
- 2022-12-27 TW TW111150221A patent/TW202333732A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024001048A5 (https=) | ||
| JP2025511227A5 (https=) | ||
| US12383528B2 (en) | Cromolyn esters and uses thereof | |
| JP2021501754A5 (https=) | ||
| JP2022000482A5 (https=) | ||
| RU2008133654A (ru) | Способ и лекарственное средство для лечения тяжелой сердечной недостаточности | |
| RU2000131183A (ru) | Производные оксииминоалкановой кислоты | |
| JP2009530393A5 (https=) | ||
| RU2009144538A (ru) | Новые циклические пептидные соединения | |
| JP2024510939A5 (https=) | ||
| AU2010324249B2 (en) | Azilsartan organic amine salts, preparation method and use thereof | |
| WO2022146914A1 (en) | Cromolyn derivatives and uses thereof | |
| JP2025501169A5 (https=) | ||
| JP2024545787A5 (https=) | ||
| SK4742001A3 (en) | Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection | |
| JPH06505265A (ja) | ヒスタミンｈ↓３受容体に対する作動的または拮抗的活性を有するイミダゾール誘導体 | |
| JP2025508359A5 (https=) | ||
| JPH10316662A5 (https=) | ||
| KR940702491A (ko) | 옥사졸리돈 유도체 | |
| JP2024540198A5 (https=) | ||
| JP2023109829A5 (https=) | ||
| US3883650A (en) | Treatment of filariasis | |
| JPS5840552B2 (ja) | １，４− ベンゾジオキサンノ アミンユウドウタイノセイホウ | |
| JP2026503618A5 (https=) | ||
| RU2003130062A (ru) | Бициклические производные гуанидина и их терапевтическое использование |